WCPO: Raising colorectal cancer awareness
UC doctor offers tips on recognizing colon cancer following untimely passing of actor Chad Boseman
Colorectal cancer is the second deadliest form of cancer, and African Americans have the highest rates of any racial or ethnic group in the U.S. Those rates are just about 10% higher for Black men than white men.
Olugbenga Olowokure, MD, associate professor at the UC College of Medicine and a UC Health oncologist, says it can be difficult to detect the disease in someone younger than 45 years old, which is when screenings are recommended.
“If (Chad Boseman) didn't have any personal family history, he wouldn't be a person we would pick up,” Olowokure says.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
The subtle changes in hearing you should never ignore
July 24, 2026
It’s easy to dismiss changes in hearing as minor. But as The Washington Post recently reported, these symptoms could also signal a medical emergency that many people don’t recognize — known as sudden sensorineural hearing loss, a rapid decline in hearing that occurs suddenly or over a few days.
UC experts say proper produce washing is key defense against Cyclospora
July 24, 2026
Hamilton County Public Health reports confirmed cases of cyclosporiasis, as concerns persist. Cyclospora is a parasite that can cause a stomach illness lasting days — sometimes even weeks. University of Cincinnati medical experts say it is usually linked to contaminated water or food, often fresh produce.
What are the options for male birth control?
July 24, 2026
Despite major advances in contraception during the past several decades, responsibility for pregnancy prevention falls largely on women. As recently reported in Endocrinology Advisor, a new generation of male contraceptive candidates is advancing into early- and mid-stage clinical trials.